Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Cocrystal Pharma, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- 0 vs. Q4 2024
- Shares held
- 748.8K
- +37.4K (+5.3%) vs. Q4 2024
- Total value
- $1.06M
- −$373.0K (−26.0%) vs. Q4 2024
- New holders
- 2
- 5 more added
- Sold out
- 2
- 5 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COCP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $1.17M |
| Q1 2026 | 26 | $783.8K |
| Q4 2025 | 28 | $754.3K |
| Q3 2025 | 22 | $831.3K |
| Q2 2025 | 22 | $1.02M |
| Q1 2025 | 24 | $1.06M |
| Q4 2024 | 24 | $1.44M |
| Q3 2024 | 20 | $1.27M |
| Q2 2024 | 14 | $1.57M |
| Q1 2024 | 16 | $1.01M |
| Q4 2023 | 17 | $1.17M |
| Q3 2023 | 16 | $1.32M |
| Q2 2023 | 20 | $1.59M |
| Q1 2023 | 21 | $1.47M |
| Q4 2022 | 21 | $2.08M |
| Q3 2022 | 27 | $3.95M |
| Q2 2022 | 33 | $5.83M |
| Q1 2022 | 34 | $7.90M |
| Q4 2021 | 35 | $9.78M |
| Q3 2021 | 41 | $16.1M |
| Q2 2021 | 42 | $25.0M |
| Q1 2021 | 35 | $13.5M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Cocrystal Pharma, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 51 | $0 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 6 | $9 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 33 | $47 | 0.00% | 00.0% | Unchanged |
| NVWM, LLC | 84 | $119 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 104 | $148 | 0.00% | −155−59.8% | Reduced |
| MAI Capital Management | 237 | $337 | 0.00% | 00.0% | Unchanged |
| Clean Yield Group | 418 | $594 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 817 | $1.16K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,957 | $2.78K | 0.00% | +1,127+135.8% | Added |
| Morgan Stanley | 5,863 | $8.33K | 0.00% | −58,483−90.9% | Reduced |
| Bank of America Corp | 9,022 | $12.8K | 0.00% | +10.0% | Added |
| Citadel Advisors LLC | 10,034 | $14.2K | 0.00% | +10,034 | New |
| Northern Trust Corp | 11,921 | $16.9K | 0.00% | −250−2.1% | Reduced |
| Dimensional Fund Advisors LP | 14,596 | $20.7K | 0.00% | −419−2.8% | Reduced |
| Parallel Advisors, LLC | 15,228 | $22.4K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 16,806 | $23.9K | 0.00% | +10,676+174.2% | Added |
| State Street Corp | 20,543 | $29.2K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 33,683 | $47.8K | 0.00% | +21,556+177.8% | Added |
| Neuberger Berman Group LLC | 59,271 | $84.2K | 0.00% | +59,271 | New |
| Geode Capital Management, LLC | 73,119 | $103.9K | 0.00% | +4,229+6.1% | Added |
| BlackRock, Inc. | 73,746 | $104.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 125,628 | $178.4K | 0.00% | −200−0.2% | Reduced |
| Vanguard Group Inc | 275,656 | $391.4K | 0.00% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −3−100.0% | Sold out |